CN Stock MarketDetailed Quotes

002099 Zhejiang Hisoar Pharmaceutical

Watchlist

5.34
+0.14+2.69%

Market Closed Dec 27 15:00 CST

8.64BMarket Cap-23.42P/E (TTM)

Zhejiang Hisoar Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Operating Cash Flow

Goods sale service render cash

-20.86%1.06B

-17.24%733.28M

-17.49%363.34M

-13.18%1.7B

-7.90%1.34B

-7.50%886.04M

-1.61%440.37M

15.24%1.96B

12.52%1.45B

17.05%957.85M

Refunds of taxes and levies

-14.47%74.64M

-13.86%50.82M

-25.38%18.98M

-46.01%100.03M

-41.65%87.27M

-49.83%59M

-18.59%25.43M

64.94%185.26M

63.78%149.56M

101.05%117.6M

Cash received relating to other operating activities

-55.20%85.54M

-43.67%65.48M

83.73%58.24M

-40.45%217.47M

-29.84%190.93M

-51.92%116.25M

-86.00%31.7M

167.03%365.21M

244.88%272.12M

409.26%241.81M

Cash inflows from operating activities

-24.57%1.22B

-19.95%849.58M

-11.45%440.57M

-19.56%2.02B

-13.78%1.62B

-19.43%1.06B

-29.46%497.51M

28.73%2.51B

28.27%1.87B

42.51%1.32B

Goods services cash paid

-32.23%647.36M

-38.16%409.24M

50.41%280.52M

-22.99%1.24B

-6.61%955.25M

-7.05%661.75M

-46.41%186.5M

82.30%1.61B

89.01%1.02B

113.27%711.93M

Staff behalf paid

1.17%248.29M

-0.56%169.73M

0.15%70.85M

-9.72%313.5M

-7.46%245.42M

-9.05%170.69M

-12.04%70.75M

-1.48%347.27M

0.20%265.21M

2.21%187.67M

All taxes paid

-27.67%53.13M

-33.61%38.59M

-13.91%27.43M

-17.32%80.3M

-20.87%73.45M

-11.61%58.13M

3.07%31.86M

-20.13%97.12M

-22.02%92.82M

-35.74%65.77M

Cash paid relating to other operating activities

38.57%130.3M

39.47%85.41M

-32.00%33.28M

-57.44%143.93M

-51.23%94.03M

-56.80%61.24M

-49.17%48.94M

-30.99%338.22M

3.40%192.8M

8.53%141.75M

Cash outflows from operating activities

-21.13%1.08B

-26.14%702.97M

21.90%412.08M

-25.70%1.78B

-13.06%1.37B

-14.03%951.8M

-39.16%338.06M

29.58%2.4B

41.60%1.57B

47.54%1.11B

Net cash flows from operating activities

-43.60%139.5M

33.90%146.61M

-82.13%28.49M

107.19%240.54M

-17.57%247.34M

-47.90%109.49M

6.57%159.45M

13.41%116.09M

-14.13%300.05M

20.82%210.14M

Investing cash flow

Cash received from disposal of investments

----

--1.5M

206.34%46.35M

196.43%44.85M

1,748.56%94.85M

----

505.25%15.13M

Cash received from returns on investments

----

--69.05M

601.37%24.2M

613.93%24.2M

----

56.59%3.45M

90.29%3.45M

Net cash received from disposal of fix assets、 intangible assets 、other long-term asset

-99.38%126.2K

----

329.61%24.34M

8,729.57%20.31M

--17.88M

--14.87M

-38.62%5.66M

217.64%230K

----

Net cash received from disposal of subsidiaries and other business units

--24M

----

Cash received relating to other investing activities

90.09%103.32M

-24.59%40.82M

23.09%4.62M

-90.30%62.41M

266.11%54.35M

588.98%54.13M

-0.31%3.76M

3,441.22%643.09M

889.67%14.85M

--7.86M

Cash inflows from investing activities

-12.24%127.44M

-71.06%40.82M

-96.64%4.62M

-75.75%157.3M

331.45%145.21M

433.55%141.06M

1,020.42%137.68M

2,058.72%648.75M

436.29%33.66M

502.85%26.44M

Cash paid to acquire fixed assets intangible assets and other long-term assets

-44.11%85.16M

-61.59%37.57M

-30.02%23.64M

-14.68%153.08M

-58.25%152.37M

-57.15%97.82M

-70.76%33.78M

-21.84%179.42M

35.76%365M

46.27%228.3M

Cash paid to acquire investments

----

-90.95%42M

-93.52%30.5M

-97.87%10M

----

84.55%464.13M

116.33%470.52M

337.69%470.52M

Cash paid relating to other investing activities

54.22%147.58M

222.35%133.74M

78.83%39.73M

-85.54%90.44M

738.26%95.69M

--41.49M

42.13%22.22M

978.47%625.51M

899.88%11.42M

----

Cash outflows from investing activities

-16.45%232.74M

14.74%171.31M

13.17%63.37M

-77.50%285.51M

-67.11%278.56M

-78.63%149.31M

-57.30%56M

135.42%1.27B

73.73%846.94M

165.13%698.82M

Net cash flows from investing activities

21.03%-105.3M

-1,483.17%-130.49M

-171.92%-58.75M

79.33%-128.21M

83.60%-133.35M

98.77%-8.24M

168.73%81.69M

-21.87%-620.32M

-69.00%-813.28M

-159.41%-672.38M

Financing cash flow

Cash received from capital contributions

----

-96.00%10K

----

--250K

-83.63%250K

--250K

-Including: Cash received from capital contributions by minority shareholders of subsidiaries

----

-96.00%10K

----

--250K

Cash from borrowing

8.23%1.99B

25.80%1.42B

5.83%1B

3.52%2.31B

-1.04%1.84B

9.81%1.12B

844.92%944.92M

108.43%2.23B

166.43%1.86B

83.25%1.02B

Cash received relating to other financing activities

-43.08%184.5M

-20.43%166.5M

728.60%175.6M

--332.56M

--324.12M

--209.24M

--21.19M

----

Cash inflows from financing activities

0.55%2.18B

18.55%1.58B

21.68%1.18B

18.43%2.64B

16.35%2.17B

30.21%1.33B

866.11%966.11M

108.46%2.23B

165.89%1.86B

83.30%1.02B

Borrowing repayment

46.25%1.93B

104.43%1.23B

92.77%685.1M

23.79%2.25B

9.89%1.32B

9.27%601M

255.40%355.4M

95.59%1.82B

155.86%1.2B

161.90%550M

Dividend interest payment

-79.31%23.21M

-81.82%17.69M

46.40%10.25M

-39.14%118.94M

-39.25%112.18M

-44.81%97.31M

53.10%7M

265.66%195.44M

301.72%184.67M

330.23%176.33M

Cash payments relating to other financing activities

15.45%316.01M

68.04%315.79M

--243.27M

-49.09%172M

68,250.70%273.73M

46,823.82%187.92M

----

5,760.60%337.85M

170.04%400.49K

--400.49K

Cash outflows from financing activities

33.04%2.27B

76.26%1.56B

159.00%938.62M

8.08%2.54B

23.07%1.7B

21.95%886.24M

246.56%362.4M

137.83%2.35B

169.26%1.39B

189.55%726.73M

Net cash flows from financing activities

-119.16%-88.62M

-95.64%19.52M

-60.75%236.98M

181.28%99.07M

-3.13%462.6M

50.36%447.92M

13,304.21%603.71M

-250.87%-121.88M

156.57%477.55M

-3.29%297.89M

Net cash flow

Exchange rate change effecting cash and cash equivalents

-50.86%13.62M

-55.78%10.44M

127.89%3.37M

-98.53%1.1M

-75.24%27.71M

-44.48%23.62M

-167.61%-12.08M

394.25%75.13M

1,207.00%111.89M

520.84%42.54M

Net increase in cash and cash equivalents

-106.75%-40.81M

-91.95%46.09M

-74.77%210.1M

138.57%212.5M

692.97%604.29M

570.22%572.79M

3,738.86%832.76M

-56.80%-550.97M

72.40%76.21M

-157.29%-121.81M

Add:Begin period cash and cash equivalents

20.49%1.25B

20.46%1.25B

-34.70%1.04B

-18.12%1.59B

End period cash equivalent

-26.36%1.21B

-19.52%1.3B

-21.95%1.46B

20.49%1.25B

-1.38%1.64B

9.80%1.61B

16.16%1.87B

-34.70%1.04B

-16.10%1.66B

-31.87%1.47B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash	-20.86%1.06B	-17.24%733.28M	-17.49%363.34M	-13.18%1.7B	-7.90%1.34B	-7.50%886.04M	-1.61%440.37M	15.24%1.96B	12.52%1.45B	17.05%957.85M
Refunds of taxes and levies	-14.47%74.64M	-13.86%50.82M	-25.38%18.98M	-46.01%100.03M	-41.65%87.27M	-49.83%59M	-18.59%25.43M	64.94%185.26M	63.78%149.56M	101.05%117.6M
Cash received relating to other operating activities	-55.20%85.54M	-43.67%65.48M	83.73%58.24M	-40.45%217.47M	-29.84%190.93M	-51.92%116.25M	-86.00%31.7M	167.03%365.21M	244.88%272.12M	409.26%241.81M
Cash inflows from operating activities	-24.57%1.22B	-19.95%849.58M	-11.45%440.57M	-19.56%2.02B	-13.78%1.62B	-19.43%1.06B	-29.46%497.51M	28.73%2.51B	28.27%1.87B	42.51%1.32B
Goods services cash paid	-32.23%647.36M	-38.16%409.24M	50.41%280.52M	-22.99%1.24B	-6.61%955.25M	-7.05%661.75M	-46.41%186.5M	82.30%1.61B	89.01%1.02B	113.27%711.93M
Staff behalf paid	1.17%248.29M	-0.56%169.73M	0.15%70.85M	-9.72%313.5M	-7.46%245.42M	-9.05%170.69M	-12.04%70.75M	-1.48%347.27M	0.20%265.21M	2.21%187.67M
All taxes paid	-27.67%53.13M	-33.61%38.59M	-13.91%27.43M	-17.32%80.3M	-20.87%73.45M	-11.61%58.13M	3.07%31.86M	-20.13%97.12M	-22.02%92.82M	-35.74%65.77M
Cash paid relating to other operating activities	38.57%130.3M	39.47%85.41M	-32.00%33.28M	-57.44%143.93M	-51.23%94.03M	-56.80%61.24M	-49.17%48.94M	-30.99%338.22M	3.40%192.8M	8.53%141.75M
Cash outflows from operating activities	-21.13%1.08B	-26.14%702.97M	21.90%412.08M	-25.70%1.78B	-13.06%1.37B	-14.03%951.8M	-39.16%338.06M	29.58%2.4B	41.60%1.57B	47.54%1.11B
Net cash flows from operating activities	-43.60%139.5M	33.90%146.61M	-82.13%28.49M	107.19%240.54M	-17.57%247.34M	-47.90%109.49M	6.57%159.45M	13.41%116.09M	-14.13%300.05M	20.82%210.14M
Investing cash flow
Cash received from disposal of investments	----	----	----	--1.5M	206.34%46.35M	196.43%44.85M	1,748.56%94.85M	----	505.25%15.13M	505.25%15.13M
Cash received from returns on investments	----	----	----	--69.05M	601.37%24.2M	601.37%24.2M	613.93%24.2M	----	56.59%3.45M	90.29%3.45M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset	-99.38%126.2K	----	----	329.61%24.34M	8,729.57%20.31M	--17.88M	--14.87M	-38.62%5.66M	217.64%230K	----
Net cash received from disposal of subsidiaries and other business units	--24M	----	----	----	----	----	----	----	----	----
Cash received relating to other investing activities	90.09%103.32M	-24.59%40.82M	23.09%4.62M	-90.30%62.41M	266.11%54.35M	588.98%54.13M	-0.31%3.76M	3,441.22%643.09M	889.67%14.85M	--7.86M
Cash inflows from investing activities	-12.24%127.44M	-71.06%40.82M	-96.64%4.62M	-75.75%157.3M	331.45%145.21M	433.55%141.06M	1,020.42%137.68M	2,058.72%648.75M	436.29%33.66M	502.85%26.44M
Cash paid to acquire fixed assets intangible assets and other long-term assets	-44.11%85.16M	-61.59%37.57M	-30.02%23.64M	-14.68%153.08M	-58.25%152.37M	-57.15%97.82M	-70.76%33.78M	-21.84%179.42M	35.76%365M	46.27%228.3M
Cash paid to acquire investments	----	----	----	-90.95%42M	-93.52%30.5M	-97.87%10M	----	84.55%464.13M	116.33%470.52M	337.69%470.52M
Cash paid relating to other investing activities	54.22%147.58M	222.35%133.74M	78.83%39.73M	-85.54%90.44M	738.26%95.69M	--41.49M	42.13%22.22M	978.47%625.51M	899.88%11.42M	----
Cash outflows from investing activities	-16.45%232.74M	14.74%171.31M	13.17%63.37M	-77.50%285.51M	-67.11%278.56M	-78.63%149.31M	-57.30%56M	135.42%1.27B	73.73%846.94M	165.13%698.82M
Net cash flows from investing activities	21.03%-105.3M	-1,483.17%-130.49M	-171.92%-58.75M	79.33%-128.21M	83.60%-133.35M	98.77%-8.24M	168.73%81.69M	-21.87%-620.32M	-69.00%-813.28M	-159.41%-672.38M
Financing cash flow
Cash received from capital contributions	----	----	----	-96.00%10K	-96.00%10K	-96.00%10K	----	--250K	-83.63%250K	--250K
-Including: Cash received from capital contributions by minority shareholders of subsidiaries	----	----	----	-96.00%10K	-96.00%10K	-96.00%10K	----	--250K	--250K	--250K
Cash from borrowing	8.23%1.99B	25.80%1.42B	5.83%1B	3.52%2.31B	-1.04%1.84B	9.81%1.12B	844.92%944.92M	108.43%2.23B	166.43%1.86B	83.25%1.02B
Cash received relating to other financing activities	-43.08%184.5M	-20.43%166.5M	728.60%175.6M	--332.56M	--324.12M	--209.24M	--21.19M	----	----	----
Cash inflows from financing activities	0.55%2.18B	18.55%1.58B	21.68%1.18B	18.43%2.64B	16.35%2.17B	30.21%1.33B	866.11%966.11M	108.46%2.23B	165.89%1.86B	83.30%1.02B
Borrowing repayment	46.25%1.93B	104.43%1.23B	92.77%685.1M	23.79%2.25B	9.89%1.32B	9.27%601M	255.40%355.4M	95.59%1.82B	155.86%1.2B	161.90%550M
Dividend interest payment	-79.31%23.21M	-81.82%17.69M	46.40%10.25M	-39.14%118.94M	-39.25%112.18M	-44.81%97.31M	53.10%7M	265.66%195.44M	301.72%184.67M	330.23%176.33M
Cash payments relating to other financing activities	15.45%316.01M	68.04%315.79M	--243.27M	-49.09%172M	68,250.70%273.73M	46,823.82%187.92M	----	5,760.60%337.85M	170.04%400.49K	--400.49K
Cash outflows from financing activities	33.04%2.27B	76.26%1.56B	159.00%938.62M	8.08%2.54B	23.07%1.7B	21.95%886.24M	246.56%362.4M	137.83%2.35B	169.26%1.39B	189.55%726.73M
Net cash flows from financing activities	-119.16%-88.62M	-95.64%19.52M	-60.75%236.98M	181.28%99.07M	-3.13%462.6M	50.36%447.92M	13,304.21%603.71M	-250.87%-121.88M	156.57%477.55M	-3.29%297.89M
Net cash flow
Exchange rate change effecting cash and cash equivalents	-50.86%13.62M	-55.78%10.44M	127.89%3.37M	-98.53%1.1M	-75.24%27.71M	-44.48%23.62M	-167.61%-12.08M	394.25%75.13M	1,207.00%111.89M	520.84%42.54M
Net increase in cash and cash equivalents	-106.75%-40.81M	-91.95%46.09M	-74.77%210.1M	138.57%212.5M	692.97%604.29M	570.22%572.79M	3,738.86%832.76M	-56.80%-550.97M	72.40%76.21M	-157.29%-121.81M
Add:Begin period cash and cash equivalents	20.49%1.25B	20.49%1.25B	20.46%1.25B	-34.70%1.04B	-34.70%1.04B	-34.70%1.04B	-34.70%1.04B	-18.12%1.59B	-18.12%1.59B	-18.12%1.59B
End period cash equivalent	-26.36%1.21B	-19.52%1.3B	-21.95%1.46B	20.49%1.25B	-1.38%1.64B	9.80%1.61B	16.16%1.87B	-34.70%1.04B	-16.10%1.66B	-31.87%1.47B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

002099 Zhejiang Hisoar Pharmaceutical

Zhejiang Hisoar Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow